Abstract-Klebsiella pneumoniae has been associated with different types of infections and one of the most important aspects of Klebsiella is the emergence of multi-drug resistant strains particularly those involved in nosocomial diseases. Fifty -nine clinical isolates were collected from different parts of India. Most of the samples were recovered from respiratory, urinary tract infection and pus cases which were followed by biochemical characterization. Twenty confirmed K. pneumoniae isolates were further tested for antimicrobial drug sensitivity and almost fifty percent of them were found to be multidrug resistant. As per our statistical data, all confirmed K.pneumoniae isolates were resistant to carbenicillin and one among them recovered from sputum sample of a pneumonic patient was resistant to all the antimicrobial agents tested except exhibiting a partial susceptibility to amikacin. In our studies we found that K.pneumoniae strains from clinical cases were highly susceptible to quinolones and the aminoglycoside, amykacin and gentamycin. At the same time over 60 % strains were resistant to chloramphenicol and tetracycline. We also found that 28 to 76 % of them were resistant to cephalosporins (ceftizoxime and cefotaxime). On the basis of statistical binomial test we conclude that piperacillin, carbenicillin, ofloxacine ampicillin, co-trimoxazole and chloramphenicol were significantly resistant, whereas cefotaxime and tetracycline were found to be moderately resistant against Klebsiella pneumoniae.
Large group teaching has always been the most popular way of teaching from past decades. It is one of the most convenient and economical ways to transfer
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.